Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female and Male patients aged 18 and more;
Confirmed diagnosis of RRMS according to the MacDonald or Poser criteria;
First indication for Betaferon treatment (as described in Summary of Product Characteristics (SmPC));
No relapse of multiple sclerosis (MS) in the last two months before the inclusion;
Walking patients having an Expanded Disability Status Scale (EDSS) score between \> 1 and \</= 4 at the inclusion visit;
Female of child-bearing potential must agree to practice adequate contraception methods over all the duration of the study;
Patient can follow all the study and comply with all procedures of the trial protocol
Laboratory evaluations (i.e. evaluation of hepatic enzymes gammaGT, full blood count and differential white blood cell \[WBC\]) must be available and the results must be normal;
Written informed consent.
You may not be if
Any contraindication to Betaferon as described in the SmPC of the product;
Patient with a previously orthopaedic surgical intervention within the past year of the inclusion;
Patient previously included in this study;
Patient previously treated within the past 3 months with Rebif, Avonex or Copaxone;
Patient previously treated within the past 12 months with Betaferon;
Participation in any clinical trial within the past 30 days involving the investigational drug intake.
